Takeda Pharmaceutical (TAK) News Today $13.28 -0.33 (-2.42%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy PlatformNovember 20 at 11:30 AM | businesswire.comAnalysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)November 19 at 11:04 AM | markets.businessinsider.comHalozyme says €2 billion takeover of Evotech would create leader in drug discoveryNovember 19 at 12:57 AM | msn.comOppenheimer Asset Management Inc. Sells 56,430 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Oppenheimer Asset Management Inc. lowered its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 22.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 197,199 shares of theNovember 17, 2024 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Short Interest Down 17.4% in OctoberTakeda Pharmaceutical Company Limited (NYSE:TAK - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 6,030,000 shares, a decline of 17.4% from the October 15th total of 7,300,000 shares. Based on an average daily trading volume, of 1,650,000 shares, the short-interest ratio is currently 3.7 days.November 15, 2024 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comBiocom California appoints two Bay Area executives to board of governorsNovember 13, 2024 | bizjournals.comXY Capital Ltd Sells 179,563 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)XY Capital Ltd cut its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 52.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 164,486 shares of the company's stock after selling 179,563 shares during the qNovember 9, 2024 | marketbeat.comSummit Global Investments Grows Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Summit Global Investments grew its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 86.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 415,558 shares of the company's stock after acquiring an additional 192,143 sharesNovember 8, 2024 | marketbeat.comAlphaCentric Advisors LLC Invests $1.14 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)AlphaCentric Advisors LLC purchased a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund purchased 80,000 shares of the company's stock, valued at approximately $1,138,November 5, 2024 | marketbeat.comRaymond James & Associates Has $2.75 Million Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Raymond James & Associates trimmed its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 24.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 193,566 shares of the compaNovember 5, 2024 | marketbeat.comTakeda Pharmaceutical Reports Strong Revenue Growth in 2024November 2, 2024 | markets.businessinsider.comTakeda Pharmaceutical Announces Robust Earnings GrowthNovember 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Takeda Pharmaceutical Company (TAK) and Voyager Therapeutics (VYGR)November 1, 2024 | markets.businessinsider.comFormer Takeda employee sentenced to nearly 4 years for fraudNovember 1, 2024 | bizjournals.comBrookline woman gets jail time for embezzling $2.5 million from TakedaNovember 1, 2024 | msn.comFormer employee sentenced to prison for embezzling over $2.5M from Massachusetts pharmaceutical companyNovember 1, 2024 | msn.comTakeda Pharmaceutical Company Limited 2025 Q2 - Results - Earnings Call PresentationOctober 31, 2024 | seekingalpha.comTakeda H1 Profit Rises; Upgrades 2024 Management GuidanceOctober 31, 2024 | markets.businessinsider.comTakeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance -- UpdateOctober 31, 2024 | marketwatch.comTakeda Pharmaceutical (NYSE:TAK) Releases FY 2024 Earnings GuidanceTakeda Pharmaceutical (NYSE:TAK) updated its FY 2024 earnings guidance. The company provided EPS guidance of 3.060-3.060 for the period.October 31, 2024 | marketbeat.comJapan's Takeda returns to Q2 profit as drugmaker recovers from impairmentsOctober 31, 2024 | reuters.comTakeda Announces Strong First Half FY2024 Results and Raises Full Year OutlookOctober 31, 2024 | businesswire.comWhat To Expect From Takeda Pharmaceutical Co Ltd (TSE:4502) Q2 2025 EarningsOctober 30, 2024 | finance.yahoo.comExelixis Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateOctober 29, 2024 | stockhouse.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Bought by Creative PlanningCreative Planning grew its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 46.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 157,630 shares of the company's stock after purchaOctober 28, 2024 | marketbeat.comTakeda and BMC team on decarbonization across health care ecosystemOctober 25, 2024 | markets.businessinsider.comTakeda and BMC partner to decarbonise US healthcare sectorOctober 25, 2024 | finance.yahoo.comTakeda Pharmaceutical (TAK) Scheduled to Post Earnings on ThursdayTakeda Pharmaceutical (NYSE:TAK) will be releasing earnings before the market opens on Thursday, October 31, Zacks reports.October 24, 2024 | marketbeat.comMassachusetts’ largest pharmaceutical company is laying off employees againOctober 22, 2024 | msn.comInvestigating Eli Lilly's Standing In Pharmaceuticals Industry Compared To CompetitorsOctober 18, 2024 | benzinga.comBleakley Financial Group LLC Boosts Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Bleakley Financial Group LLC increased its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 11.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 335,170 shares of the company's stock after buyinOctober 18, 2024 | marketbeat.comPetri Dish: Takeda splits from Wave; Lilly backs Alzheimer’s biotechOctober 17, 2024 | bizjournals.comStrategic Moves in the Japanese Market: T. Rowe Price Japan Fund's Focus on Takeda PharmaceuticalOctober 16, 2024 | finance.yahoo.comSurvey finds 6% of U.S. adults have ADHD amid ongoing drug shortagesOctober 13, 2024 | msn.comAQR Capital Management LLC Buys 54,539 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)AQR Capital Management LLC increased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 153.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,013 shares of the cOctober 12, 2024 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Sees Strong Trading Volume - Here's WhyTakeda Pharmaceutical (NYSE:TAK) Sees Large Volume Increase - Should You Buy?October 11, 2024 | marketbeat.comLGND: Initiating Coverage – A Prince Among RoyaltyOctober 9, 2024 | finance.yahoo.comCreative Planning Lowers Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Creative Planning trimmed its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 25.7% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 107,759 shares of the company's stock after selling 37,369 shares during the period. CreativeOctober 9, 2024 | marketbeat.comClean Yield Group Has $5.78 Million Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Clean Yield Group cut its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 8.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 406,228 shares of the company's stock after selling 38,912 shares during the period. TakeOctober 8, 2024 | marketbeat.comTakeda Pharmaceutical: An Interesting Option For Income InvestorsOctober 7, 2024 | seekingalpha.comSei Investments Co. Decreases Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Sei Investments Co. reduced its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 10.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 333,740 shares of the company's stock after selOctober 2, 2024 | marketbeat.comMillennium Management LLC Increases Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Millennium Management LLC grew its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 87.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,346,151 shares of the company'October 1, 2024 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Brandes Investment Partners LPBrandes Investment Partners LP decreased its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 9.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,635,027 shares of the companSeptember 30, 2024 | marketbeat.comRevSavvy Debuts Automated Revisions & Compliance Platform - ARC - and New Technology Partnership with CGI GlobalSeptember 24, 2024 | tmcnet.comTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backingSeptember 24, 2024 | lse.co.ukMercer Global Advisors Inc. ADV Sells 39,782 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Mercer Global Advisors Inc. ADV cut its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 19.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 170,056 shares of the company's stock afterSeptember 24, 2024 | marketbeat.comTakeda marks 10 years in Vietnam with new dengue vaccine approvalSeptember 23, 2024 | msn.comAnalysts Predict 85% Upside for Wave Life Sciences After Rate Cut (TAK)Wave Life Sciences has received recent Wall Street price targets forecasting big upside. The company has a potentially "industry-leading" treatment.September 20, 2024 | marketbeat.comTakeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024September 19, 2024 | businesswire.com Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! TAK Media Mentions By Week TAK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼0.500.45▲Average Medical News Sentiment TAK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼54▲TAK Articles Average Week Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News Today GSK News Today BNTX News Today TEVA News Today BGNE News Today VTRS News Today SMMT News Today MRNA News Today GMAB News Today RDY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TAK) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TAK Stock Alerts